---
title: "NKGen Biotech to Present Troculeucel Mechanism Data in Alzheimer’s and Frontotemporal Dementia at the Neuroimmunology Drug Development Summit | NKGN Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282191160.md"
description: "NKGen Biotech to Present Troculeucel Mechanism Data in Alzheimer’s and Frontotemporal Dementia at the Neuroimmunology Drug Development Summit | NKGN Stock News"
datetime: "2026-04-09T04:05:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282191160.md)
  - [en](https://longbridge.com/en/news/282191160.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282191160.md)
generator: "portal-rs"
---

# NKGen Biotech to Present Troculeucel Mechanism Data in Alzheimer’s and Frontotemporal Dementia at the Neuroimmunology Drug Development Summit | NKGN Stock News

NKGen Biotech to Present Troculeucel Mechanism Data in Alzheimer’s and Frontotemporal Dementia at the Neuroimmunology Drug Development Summit | NKGN Stock News

### Related Stocks

- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [NKGN.US](https://longbridge.com/en/quote/NKGN.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)

## Related News & Research

- [NKGen Biotech amends convertible loan deal with AlpineBrook, adds USD 1.05 million note](https://longbridge.com/en/news/297830645.md)
- [NKGen Biotech Amends $5 Million BDW Loan, Pledging Real Estate as First-Lien Collateral](https://longbridge.com/en/news/293074756.md)
- [Sacituzumab Govitecan Plus Pembrolizumab Does Not Meet Primary Endpoints in First-Line PD-L1-High Metastatic NSCLC](https://longbridge.com/en/news/298830378.md)
- [FDA grants priority review to Genentech’s Enspryng for MOGAD](https://longbridge.com/en/news/298539804.md)
- [09:28 ETNew LabCentral Program "The Loop" Offers International Biotech Start-Ups and Partner Organizations Curated Learnings Directly from U.S. Market](https://longbridge.com/en/news/298328140.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**